FDA to allow mix and match of COVID-19 booster vaccines- NYT

The government would not recommend one shot over another, and it might note that using the same vaccine as a booster when possible is preferable, the NYT report said.

Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021.  (photo credit: REUTERS/DADO RUVIC/ILLUSTRATION/FILE PHOTO)
Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021.
(photo credit: REUTERS/DADO RUVIC/ILLUSTRATION/FILE PHOTO)

The US Food and Drug Administration is planning to allow Americans to get a different booster shot of a COVID-19 vaccine than the one initially taken, the New York Times reported on Monday night.

The FDA in September authorized a booster dose of Pfizer Inc and partner BioNTech's two-shot COVID-19 vaccine for those aged 65 and older and some high-risk Americans.

The regulator's advisory panel has also backed the use of Moderna Inc and Johnson & Johnson's COVID-19 vaccine booster shots.

The government would not recommend one shot over another, and it might note that using the same vaccine as a booster when possible is preferable, the NYT report said, citing people familiar with the agency's plans.

The FDA declined to comment on the matter.

VIALS LABELED ‘COVID-19 Coronavirus Vaccine’ and a syringe are seen in front of displayed Johnson&Johnson logo. (credit: DADO RUVIC/REUTERS)VIALS LABELED ‘COVID-19 Coronavirus Vaccine’ and a syringe are seen in front of displayed Johnson&Johnson logo. (credit: DADO RUVIC/REUTERS)

US health officials have been under pressure to authorize the additional shots after the White House announced plans in August for a widespread booster campaign pending approvals from the FDA and the US Centers for Disease Control and Prevention.

A study by the National Institutes of Health last week showed people who got Johnson & Johnson's COVID-19 vaccine as a first shot had a stronger immune response when boosted with vaccines from Pfizer and Moderna.